Impact of etiology of hepatocellular carcinoma on treatment outcomes in a real-world database.

Authors

Timothy Brown

Timothy J Brown

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;

Timothy J Brown , Ronac Mamtani , Phyllis A. Gimotty , Thomas Benjamin Karasic , Yu-Xiao Yang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 508)

DOI

10.1200/JCO.2023.41.4_suppl.508

Abstract #

508

Poster Bd #

A18

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE).

Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE).

First Author: Parthib Das

First Author: Ghassan K. Abou-Alfa